Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,231 public trials 1,017 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma

NCT00101283

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +11 more
Locations
  • Eastern Connecticut Hematology and Oncology Associates Norwich, Connecticut, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
View all 115 locations
View Trial Details
Completed

A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors

NCT05116891

Conditions
Advanced Solid Tumors, Biliary Tract Cancer, Biliary Tract Diseases, +22 more
Locations
  • EDOG Institut de Cancerologie de l'Ouest - PPDS Saint-Herblain, Boulevard Jacques Monod, France
  • Centre Georges François Leclerc Dijon, Côte-d'Or, France
  • Institut Bergonie Bordeaux, France
  • Centre Eugene Marquis Rennes, France
View Trial Details
Completed

Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours

NCT02482311

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +26 more
Locations
  • Research Site Fayetteville, Arkansas, United States
  • Research Site San Francisco, California, United States
  • Research Site West Hollywood, California, United States
  • Research Site Fort Myers, Florida, United States
View all 16 locations
View Trial Details
Completed

TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers

NCT03829436

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations
  • University of California - San Francisco San Francisco, California, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer

NCT01824901

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Emory University Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Eastern Cooperative Oncology Group (ECOG) Research Base Brookline, Massachusetts, United States
View Trial Details
Completed

A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung Cancer

NCT01454934

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Los Angeles, California, United States
  • Pleasant Hill, California, United States
  • San Diego, California, United States
  • Aurora, Colorado, United States
View all 83 locations
View Trial Details
Completed

Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer

NCT01104155

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Bessemer, Alabama, United States
  • Birmingham, Alabama, United States
  • Beverly Hills, California, United States
  • La Jolla, California, United States
View all 64 locations
View Trial Details
Completed

A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects

NCT02797977

Conditions
Advanced Solid Tumors, Anemia, Anemia, Aplastic, +25 more
Locations
  • Hospital Universitario Vall d'Hebron Barcelona, Spain
  • Hospital Clinic de Barcelona Barcelona, Spain
  • START Madrid Madrid, Spain
  • Hospital Universitario 12 de Octobre Madrid, Spain
View all 20 locations
View Trial Details
Completed

A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies

NCT04440943

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Urothelial Carcinoma, +61 more
Locations
  • Northside Hospital Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
  • Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha, Nebraska, United States
  • Duke Cancer Center Durham, North Carolina, United States
View Trial Details

Related conditions